TMCI Q1 2024 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena

TMCITreace Medical Concepts, Inc.

$104M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$51M+21.1% YoY

Gross Profit

$41M80.2% margin

Operating Income

-$19M-37.1% margin

Net Income

-$19M-36.5% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-17.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$243M

Total Liabilities

$116M

Stockholders' Equity

$126M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$42M	+21.1%
Gross Profit	$41M	$34M	+20.0%
Operating Income	-$19M	-$14M	-37.7%
Net Income	-$19M	-$13M	-38.8%